NPCA Quality Improvement Workshop 2021

Reducing variation in the treatment of men with high-risk/locally advanced prostate cancer

Thursday 16th December 2021
9am – 11am, online via Zoom

Session 1

Chair: Noel Clarke, NPCA Uro-Oncological Clinical Lead

Impact of the Covid-19 pandemic: findings from the National Prostate Cancer Audit

Julie Nossiter

NPCA Audit Lead, RCS/ Assistant Professor, LSHTM

Watch the video

Download the slides

Update on NHS England’s Data and Action Plan

Peter Johnson

National Clinical Director for Cancer, NHS England/ Professor of Medical Oncology, University Hospital, Southampton


Watch the video

Download the slides

Session 2

Chair: Heather Payne, NPCA Oncological Clinical Lead

Determinants of variation in radical local treatment for men with high-risk localised or locally advanced prostate cancer in England

Matt Parry

NPCA Clinical Fellow/ Urology Registrar

Watch the video

Download the slides

Optimising the management of patients with high risk/locally advanced disease – improving the outcomes of older men

Danielle Harari

Geriatric-oncology Consultant and Clinical Lead, Geriatric Oncology liaison Development Team, Guy’s and St. Thomas’

Presented by Ajay Aggarwal, NPCA Oncology Coordinator/ Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Trust and Associate Professor, LSHTM

Watch the video

Download the slides

How do we reduce variation in access to treatment for all men? The experience of black and ethnic minority groups

Jonathan Makanjuola

Consultant Urological Surgeon, King’s College Hospital


Watch the video

Download the slides

NPCA QI workshop programme

Last updated: 31 January 2022, 3:56pm